US$ 21.34
glp-1 massachusetts Medications: Access, Affordability, and What Comes Next – Mass Retirees Use, cost of weight-loss drugs
Description
T.HerrmannE.BromM.KepplerD

Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point

Suppression of an ethanol withdrawal syndrome in rats by butyrate, lactate and beta-hydroxybutyrate

379 GLP-1RAs, particularly PF1801, have demonstrated effective relief in inflammatory myopathies, such as polymyositis (PM), through preclinical studies

Sharing stories (like I skipped the donuts today!) builds accountability
